Harvard Women's Health Watch

In the News: Heart failure risk prompts warning labels on diabetes drugs

The FDA has ordered a warning label be put on the diabetes drugs Avandia and Actos due to evidence from studies that the medications may increase the risk of heart attack or death from cardiovascular disease.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In